Acadia Healthcare Company, Inc. $ACHC Shares Bought by Strs Ohio

Strs Ohio raised its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 15,846.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 347,637 shares of the company’s stock after purchasing an additional 345,457 shares during the quarter. Strs Ohio owned 0.38% of Acadia Healthcare worth $8,131,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the stock. Invenomic Capital Management LP increased its position in shares of Acadia Healthcare by 41.6% in the third quarter. Invenomic Capital Management LP now owns 1,936,396 shares of the company’s stock valued at $47,945,000 after buying an additional 568,796 shares in the last quarter. Aberdeen Group plc raised its position in shares of Acadia Healthcare by 72.3% in the fourth quarter. Aberdeen Group plc now owns 743,925 shares of the company’s stock valued at $10,556,000 after buying an additional 312,172 shares during the last quarter. Aristotle Capital Boston LLC grew its position in shares of Acadia Healthcare by 15.4% in the third quarter. Aristotle Capital Boston LLC now owns 663,653 shares of the company’s stock valued at $16,432,000 after purchasing an additional 88,361 shares in the last quarter. Abrams Bison Investments LLC increased its holdings in shares of Acadia Healthcare by 22.3% in the third quarter. Abrams Bison Investments LLC now owns 4,380,000 shares of the company’s stock valued at $108,449,000 after purchasing an additional 800,000 shares during the last quarter. Finally, P2 Capital Partners LLC lifted its position in Acadia Healthcare by 9.1% during the third quarter. P2 Capital Partners LLC now owns 2,337,188 shares of the company’s stock worth $57,869,000 after buying an additional 195,000 shares in the last quarter.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. UBS Group lifted their price target on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, April 17th. Guggenheim lifted their price target on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research report on Monday, May 4th. TD Cowen boosted their price target on shares of Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a research note on Tuesday, April 28th. Barclays increased their target price on Acadia Healthcare from $20.00 to $25.00 and gave the stock an “equal weight” rating in a research note on Thursday, April 30th. Finally, Royal Bank Of Canada raised their target price on Acadia Healthcare from $28.00 to $31.00 and gave the company an “outperform” rating in a report on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $26.85.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $31.91 on Monday. The firm has a 50 day moving average of $25.70 and a two-hundred day moving average of $21.29. The stock has a market capitalization of $2.93 billion, a PE ratio of -2.61, a P/E/G ratio of 10.64 and a beta of 0.64. The company has a quick ratio of 1.71, a current ratio of 1.71 and a debt-to-equity ratio of 1.27. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $32.82.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.28 by $0.09. The business had revenue of $828.80 million for the quarter, compared to analysts’ expectations of $823.51 million. Acadia Healthcare had a positive return on equity of 7.09% and a negative net margin of 32.84%.The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period last year, the firm earned $0.40 earnings per share. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, research analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

About Acadia Healthcare

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.